Clinical Trial Update: ELECTOR Treat-to-target Via Home-based Disease Activity Monitoring of Patients With Rheumatoid Arthritis [NA]

View source ↗

Summary

The ELECTOR trial evaluating treat-to-target using home-based disease activity monitoring for rheumatoid arthritis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Frederiksberg University Hospital | Conditions: Arthritis, Rheumatoid, Telerehabilitation | NA | Status: WITHDRAWN